Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,345
Closed -$392K 69
2020
Q1
$392K Buy
+5,345
New +$420K 0.21% 51
2019
Q2
Sell
-3,511
Closed -$279K 79
2019
Q1
$279K Buy
+3,511
New +$263K 0.12% 67

Other funds holding MRK

Birinyi Associates's MRK Position: Q2 2020 in Review

Birinyi Associates sold out of Merck (MRK) in Q2 2020, closing a stake of 5,345 shares — an estimated $392K sold.

Birinyi Associates first reported a position in MRK in Q1 2019 and held it in 2 quarters. The position peaked at $392K in Q1 2020. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Birinyi Associates reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • Birinyi Associates sold 5,345 Merck shares in Q2 2020, an estimated $392K.
  • Birinyi Associates first reported a position in Merck in Q1 2019 and held it in 2 quarters.
  • Birinyi Associates's Merck position peaked at $392K in Q1 2020.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Birinyi Associates's 13F filing for Q2 2020, filed 6 Aug 2020.